Baystate Wealth Management LLC Bristol Myers Squibb CO Transaction History

Baystate Wealth Management LLC

$1.36 Billion
Q4 2023

A detailed history of Baystate Wealth Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Baystate Wealth Management LLC holds 1,179 shares of BMY stock, worth $64,043. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,179

Previous 1,304 9.59%

Holding current value

$64,043

Previous $75,000 20.0%

% of portfolio

0.0%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 29, 2024	SELL	$48.48 - $57.85 $6,060 - $7,231	-125 Reduced 9.59%	1,179 $60,000
Q3 2023 Oct 25, 2023	SELL	$57.89 - $64.73 $752 - $841	-13 Reduced 0.99%	1,304 $75,000
Q2 2023 Sep 21, 2023	SELL	$63.71 - $70.74 $1.57 Million - $1.75 Million	-24,677 Reduced 94.93%	1,317 $84,000
Q2 2023 Aug 02, 2023	BUY	$63.71 - $70.74 $1.57 Million - $1.74 Million	24,661 Added 1850.04%	25,994 $1.66 Million
Q1 2023 Apr 25, 2023	BUY	$65.71 - $74.53 $1,379 - $1,565	21 Added 1.6%	1,333 $92,000
Q4 2022 Jan 12, 2023	BUY	$68.48 - $81.09 $15,065 - $17,839	220 Added 20.15%	1,312 $94,000
Q3 2022 Nov 10, 2022	BUY	$0.13 - $76.84 $0 - $537	7 Added 0.65%	1,092 $78,000
Q2 2022 Aug 02, 2022	BUY	$72.62 - $79.98 $580 - $639	8 Added 0.74%	1,085 $84,000
Q1 2022 Apr 19, 2022	BUY	$61.48 - $73.72 $553 - $663	9 Added 0.84%	1,077 $79,000
Q4 2021 Jan 21, 2022	BUY	$53.63 - $62.52 $482 - $562	9 Added 0.85%	1,068 $67,000
Q3 2021 Nov 05, 2021	SELL	$59.17 - $69.31 $5,384 - $6,307	-91 Reduced 7.91%	1,059 $63,000
Q2 2021 Jul 26, 2021	BUY	$61.91 - $67.42 $31,945 - $34,788	516 Added 81.39%	1,150 $77,000
Q1 2021 Apr 21, 2021	BUY	$59.34 - $66.74 $296 - $333	5 Added 0.79%	634 $40,000
Q4 2020 Jan 15, 2021	SELL	$57.74 - $65.43 $18,880 - $21,395	-327 Reduced 34.21%	629 $39,000
Q3 2020 Oct 14, 2020	BUY	$57.43 - $63.64 $29,289 - $32,456	510 Added 114.35%	956 $58,000
Q2 2020 Jul 28, 2020	BUY	$54.82 - $64.09 $1,151 - $1,345	21 Added 4.94%	446 $26,000
Q1 2020 Apr 22, 2020	BUY	$46.4 - $67.43 $139 - $202	3 Added 0.71%	425 $24,000
Q4 2019 Jan 21, 2020	BUY	$49.21 - $64.19 $4,379 - $5,712	89 Added 26.73%	422 $27,000
Q3 2019 Oct 30, 2019	BUY	$42.77 - $50.71 $171 - $202	4 Added 1.22%	333 $17,000
Q2 2019 Jul 02, 2019	BUY	$44.62 - $49.34 $669 - $740	15 Added 4.78%	329 $15,000
Q1 2019 Apr 25, 2019	BUY	$45.12 - $53.8 $135 - $161	3 Added 0.96%	314 $14,000
Q4 2018 Jan 24, 2019	SELL	$48.76 - $63.23 $24,282 - $31,488	-498 Reduced 61.56%	311 $16,000
Q3 2018 Oct 16, 2018	BUY	$55.19 - $62.25 $18,212 - $20,542	330 Added 68.89%	809 $49,000
Q2 2018 Jul 17, 2018	SELL	$50.53 - $62.98 $18,089 - $22,546	-358 Reduced 42.77%	479 $27,000
Q1 2018 Apr 24, 2018	SELL	$59.92 - $68.98 $37,809 - $43,526	-631 Reduced 42.98%	837 $43,000
Q4 2017 Jan 23, 2018	BUY	$59.94 - $65.35 $73,186 - $79,792	1,221 Added 494.33%	1,468 $93,000
Q3 2017 Oct 10, 2017	BUY	$55.23 - $63.74 $13,641 - $15,743	247	247 $16,000

Others Institutions Holding BMY

# of Institutions

2,449

Shares Held

1.51B

Call Options Held

29.7M

Put Options Held

32.1M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baystate Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baystate Wealth Management LLC with notifications on news.

Account

Baystate Wealth Management LLC Bristol Myers Squibb CO Transaction History